Evrim Resources EBIT margin
What is the EBIT margin of Evrim Resources?
The EBIT margin of Evrim Resources Corp. is -254,529.87%
What is the definition of EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin of companies in the Materials sector on OTC compared to Evrim Resources
What does Evrim Resources do?
Orogen Royalties Inc. operates as a mineral exploration company. It primarily explores for gold, copper, silver, and precious and base metal deposits. The company was formerly known as Evrim Resources Corp. and changed its name to Orogen Royalties Inc. in August 2020. Orogen Royalties Inc. was incorporated in 2005 and is headquartered in Vancouver, Canada.
Companies with ebit margin similar to Evrim Resources
- Lydian International has EBIT margin of -385,851.81%
- Clime Investment Management has EBIT margin of -332,352.17%
- Concert Pharmaceuticals Inc has EBIT margin of -300,735.71%
- Transgene Biotek has EBIT margin of -299,390.78%
- Oragenics Inc has EBIT margin of -260,928.85%
- Mydecine Innovations has EBIT margin of -258,137.62%
- Evrim Resources has EBIT margin of -254,529.87%
- Kazia Therapeutics has EBIT margin of -248,657.02%
- Tocagen has EBIT margin of -194,211.11%
- Armada Metals Ltd has EBIT margin of -192,107.65%
- Nemaura Medical Inc has EBIT margin of -178,352.64%
- Trillium Therapeutics Inc has EBIT margin of -161,183.72%
- Titan Pharmaceuticals, (de) has EBIT margin of -135,800.00%